Last updated: 2 February 2024 at 8:00pm EST

Eugene Schneider Net Worth




The estimated Net Worth of Eugene Schneider is at least $2.28 Миллион dollars as of 1 February 2024. Eugene Schneider owns over 2,071 units of Ionis Pharmaceuticals Inc stock worth over $2,118,504 and over the last 4 years Eugene sold IONS stock worth over $160,168.

Eugene Schneider IONS stock SEC Form 4 insiders trading

Eugene has made over 10 trades of the Ionis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Eugene sold 2,071 units of IONS stock worth $102,701 on 1 February 2024.

The largest trade Eugene's ever made was exercising 25,000 units of Ionis Pharmaceuticals Inc stock on 26 December 2023 worth over $1,183,500. On average, Eugene trades about 5,214 units every 70 days since 2021. As of 1 February 2024 Eugene still owns at least 49,812 units of Ionis Pharmaceuticals Inc stock.

You can see the complete history of Eugene Schneider stock trades at the bottom of the page.



What's Eugene Schneider's mailing address?

Eugene's mailing address filed with the SEC is 2855 GAZELLE COURT, , CARLSBAD, CA, 92010.

Insiders trading at Ionis Pharmaceuticals Inc

Over the last 9 years, insiders at Ionis Pharmaceuticals Inc have traded over $32,069,332 worth of Ionis Pharmaceuticals Inc stock. The most active insiders traders include Stanley T Crooke, B Lynne Parshall и Michael R Hayden. On average, Ionis Pharmaceuticals Inc executives and independent directors trade stock every 8 days with the average trade being worth of $445,289. The most recent stock trade was executed by Richard S Geary on 28 August 2024, trading 651 units of IONS stock currently worth $32,159.



What does Ionis Pharmaceuticals Inc do?

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.



What does Ionis Pharmaceuticals Inc's logo look like?

Ionis Pharmaceuticals Inc logo

Complete history of Eugene Schneider stock trades at Ionis Pharmaceuticals Inc

Дата
#
Компания
инсайдер
Транзакция
Транзакция
Акции Цена за акцию Общая стоимость Акции после Источник
1 Feb 2024 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Продажа 2,071 $49.59 $102,701
1 Feb 2024
49,812
16 Jan 2024 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 15,162 $51.03 $773,717
16 Jan 2024
53,332
12 Jan 2024 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 8,000 $32.60 $260,800
12 Jan 2024
46,170
26 Dec 2023 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 25,000 $47.34 $1,183,500
26 Dec 2023
61,052
3 Feb 2023 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Продажа 1,413 $40.67 $57,467
3 Feb 2023
24,946
17 Jan 2023 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 13,046 $39.80 $519,231
17 Jan 2023
27,078
17 Oct 2022 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 416 $46.52 $19,352
17 Oct 2022
14,176
18 Jan 2022 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 10,400 $30.12 $313,248
18 Jan 2022
17,575
15 Oct 2021 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 417 $35.10 $14,637
15 Oct 2021
7,320
15 Jan 2021 Eugene Schneider
Исполнительный вице-президент и Chf Clinical Develop Ofcr
Реализация опциона 7,503 $61.28 $459,784
15 Jan 2021
9,621


Ionis Pharmaceuticals Inc executives and stock owners

Ionis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: